Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-01-31 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document is a formal announcement dated January 31, 2014, referencing the Danish Securities Trading Act (Værdipapirhandelslovens paragraf 28a). It details a specific transaction: the 'Salg af aktier' (Sale of shares) by Novo A/S, a related party to the chairman, involving a specific number of Novozymes B-shares and the transaction value. This type of filing, reporting personal share transactions by directors or related parties, directly corresponds to the definition of Director's Dealing (DIRS). The document is short and contains specific transaction details, confirming it is a direct report of insider activity, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2014-01-31 English
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-01-30 Danish
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is dated January 30, 2014, and explicitly states it is a public disclosure ('offentliggør') according to the Danish Securities Trading Act ('Værdipapirhandelslovens paragraf 28a'). It details a specific transaction: the 'Salg af aktier' (Sale of shares) by Novo A/S, which is related to a director (Henrik Gürtler). This structure—reporting personal share transactions by directors or related parties—directly matches the definition of Director's Dealing. The code for this is DIRS.
2014-01-30 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-01-29 Danish
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is a formal announcement dated January 29, 2014, detailing a transaction involving Novozymes shares by a related party (Novo A/S, which is related to the chairman of the board). The key elements are the 'Salg af aktier' (Sale of shares), the transaction size (-50,000 shares), and the reference to Danish securities trading law ('Værdipapirhandelslovens paragraf 28a'). This structure precisely matches the definition of a Director's Dealing report, which covers personal share transactions by directors and executives (insider trades), even when the transaction is conducted by a closely related entity like a major shareholder connected to the board chairman. The code for this is DIRS.
2014-01-29 English
Report Publication Announcement 2014
Report Publication Announcement Classification · 95% confidence The document text is extremely short (145 characters) and mentions a specific date, time, and location ('Ballerup Super Arena... Wednesday February 26, 2014 at 4:00 p.m.'). Crucially, it ends with the instruction: 'Read the full announcement in PDF format.' This strongly indicates that the current text is merely an announcement or notice about a larger document, not the document itself. Given the context of a specific event time and location, it is likely related to a shareholder meeting or a general announcement. Since it explicitly points to a PDF announcement rather than being the full report, it fits the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). As it seems to be announcing the availability of an official document, RPA is the most precise fit, although RNS is a possibility if the announcement itself is the primary filing.
2014-01-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.